Stockreport

FSI ANNOUNCES CAPEX EXPENDITURE TO ACQUIRE A VIAL FILLING LINE FOR INJECTABLE DRUGS SUCH AS GLP1 FOR WEIGHT LOSS

Flexible Solutions International Inc. (CDA)  (FSI) 
NASDAQ:AMEX Investor Relations: flexiblesolutions.com/investor/default.aspx
PDF VICTORIA, BRITISH COLUMBIA, June 05, 2024 (GLOBE NEWSWIRE) -- FLEXIBLE SOLUTIONS INTERNATIONAL, INC. (NYSE-AMERICAN: FSI), is the developer and manufacturer of biodegr [Read more]